Atara Biotherapeutics (ATRA) Q3 2024 Earnings Report
CH:ATRA Q3 2024 EPS Results
- Actual EPS
- -CHF 2.42
- Consensus EPS
- -CHF 1.56
- Beat/Miss
- Missed by -CHF 0.86
- One Year Ago EPS
- -CHF 13.61
CH:ATRA Q3 2024 Revenue Results
- Actual Revenue
- CHF 33.15M
- Expected Revenue
- CHF 23.64M
- Beat/Miss
- Beat by +CHF 9.51M
- YoY Revenue Growth
- +1779.79%
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 11/12/2024
- Time
- After Close
- Conference Call
- Tuesday, November 12, 2024
CH:ATRA Upcoming Earnings
Atara Biotherapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q3 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2024 Earnings Slide Deck
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:ATRA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | ―- | -0.21 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.11- | -0.26 | ― | |
| Aug 12, 2026 | 2026 (Q2) | -0.26-0.26 | 0.16 | -268.42% (-0.42) | |
| May 12, 2026 | 2026 (Q1) | -0.27-0.24 | 2.89 | -108.29% (-3.13) | |
| Mar 16, 2026 | 2025 (Q4) | -0.15-0.21 | -0.98 | 78.99% (+0.78) | |
| Nov 29, 2025 | 2025 (Q3) | -0.55-0.26 | -2.42 | 89.08% (+2.15) | |
| Aug 11, 2025 | 2025 (Q2) | -0.050.16 | -2.56 | 106.13% (+2.71) | |
| May 15, 2025 | 2025 (Q1) | -1.632.89 | -4.74 | 160.87% (+7.63) | |
| Mar 07, 2025 | 2024 (Q4) | -2.36-0.98 | -11.55 | 91.50% (+10.57) | |
| Nov 12, 2024 | 2024 (Q3) | -1.56-2.42 | -13.61 | 82.24% (+11.19) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
